Efficacy and Safety of Deferasirox Across Underlying Non-Transfusion-Dependent Thalassemia Syndromes: 1-Year Results From the THETIS Study
dc.contributor.author | Zhu, Z. | |
dc.contributor.author | KARAKAŞ, Zeynep | |
dc.contributor.author | Taher, A. | |
dc.contributor.author | Schaefer, F. | |
dc.contributor.author | Wang, C. | |
dc.contributor.author | Cappellini, M. | |
dc.contributor.author | Viprakasit, V. | |
dc.contributor.author | AYDINOK, YEŞİM | |
dc.contributor.author | Porter, J. | |
dc.contributor.author | Lai, Y. | |
dc.contributor.author | Siritanaratkul, N. | |
dc.contributor.author | Kattamis, A. | |
dc.date.accessioned | 2021-03-06T21:02:14Z | |
dc.date.available | 2021-03-06T21:02:14Z | |
dc.identifier.citation | Cappellini M., Viprakasit V., AYDINOK Y., Porter J., Lai Y., Siritanaratkul N., KARAKAŞ Z., Kattamis A., Wang C., Zhu Z., et al., "Efficacy and Safety of Deferasirox Across Underlying Non-Transfusion-Dependent Thalassemia Syndromes: 1-Year Results From the THETIS Study", Annual Meeting of the Society-for-the-Advancement-of-Blood-Management, Oregon, Amerika Birleşik Devletleri, 01 Ocak 2017, cilt.123, ss.1-2 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_fce63ebd-d38c-42ee-bd31-cb18749b39a3 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/165493 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Anesteziyoloji | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ANESTEZİYOLOJİ | |
dc.title | Efficacy and Safety of Deferasirox Across Underlying Non-Transfusion-Dependent Thalassemia Syndromes: 1-Year Results From the THETIS Study | |
dc.type | Bildiri | |
dc.contributor.department | University Of Milan , , | |
dc.identifier.volume | 123 | |
dc.contributor.firstauthorID | 2203406 |
Bu öğenin dosyaları:
Dosyalar | Boyut | Biçim | Göster |
---|---|---|---|
Bu öğe ile ilişkili dosya yok. |
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]